Entrepreneur News Network

Immuneel Therapeutics Raises ₹100 Crore in Series B Funding to Expand Cancer Cell Therapy Business

Immuneel Therapeutics

Indian biotechnology company Immuneel Therapeutics has secured ₹100 crore (approximately $10.5 million) in a Series B funding round, attracting participation from both new and existing investors as it accelerates the development and commercialization of advanced cancer therapies. The latest funding round saw investments from Singularity AMC, Rainmatter by Zerodha, and several high-net-worth individuals. Existing backers … Read more

Nanochon Secures $11.3 Million in Oversubscribed Funding

Nanochon

Washington, D.C., January 12, 2026 — Nanochon, a Washington, D.C.-based orthopedic device company developing next-generation implants for articular cartilage repair, has announced the close of an oversubscribed funding round, bringing its total capital raised to $11.3 million to date. The latest round was led by cultivate(MD), with strong participation from The University of Virginia (UVA) … Read more